Biotech & pharma
The biology behind schizophrenia
02 Aug 2014
The research, the largest genomic study published on any psychiatric disorder to date, provides important new insights about the biological causes of schizophrenia, that could lead to new approaches to treatment
Piggy-backing cells hold clue to cancer growth
02 Aug 2014
Researchers find mechanism that clears excess of a pancreatic protein linked with Type 2 diabetes
25 Jul 2014
Biology behind schizophrenia
22 Jul 2014
Why birds don’t spread Lassa fever
04 Jul 2014
Researchers regrow human corneas; could reverse blindness
04 Jul 2014
Boston researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule that acts as a marker for hard-to-find limbal stem cells
NMR provides fresh atomic insights into a key protein that helps repair DNA
03 Jul 2014
Scientists have made an important advance in understanding how a protein that identifies and repairs cancerous cells operates
Controlling movement with light
By By Anne Trafton | MIT News Office | 30 Jun 2014
Research finds cell division synchronised to cell and body’s daily clock
28 Jun 2014
The finding could optimise timing of chemotherapy and explain the occurrence of some cancers
The brain’s balancing act
26 Jun 2014
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
